RxDoctor Payments Data

Cameron Akbari, MD

Vascular Surgery · Prince Frederick, MDNPI 1609854645

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Inari Medical, Inc. at 44.8% of the total. Reporting peaked in 2024 at $1,704 and has fallen 88.6% since, to $195 in 2025. That places this record below the midpoint for vascular surgery clinicians in MD, where the typical reported total is $3,095.

$3,368in general payments, 2019–2025

Across 53 payments — averaging $63.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$2K
  • Silk Road Medical, Inc.$632
  • Cagent Vascular Inc$232
  • Bard Peripheral Vascular, Inc.$225
  • Integra Lifesciences Corporation$131
  • Cook Medical LLC$119
  • plus $521 from 11 others
$12,284in research payments, 2019–2025

Across 3 payments — averaging $4094.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$12K

What the payments were for

  • Travel & lodging$1,70551%
  • Food & beverage$1,62948%
  • Education$341%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,368 in reported general payments places this provider in the 50th percentile of 104 vascular surgery providers in Maryland.

See all vascular surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$339,239
Medicare patients
844
Services billed
1,870

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate29$190
Atorvastatin Calcium14$166

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Prince Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →